STAT Plus Pharmalittle Regeneron and Sanofi drop price on cholesterol drug; abortion pill restrictions are obstacles to docs

STAT Plus: Pharmalittle: Regeneron and Sanofi drop price on cholesterol drug; abortion pill restrictions are obstacles to docs

Regeneron Pharmaceuticals and Sanofi will cut the price of a cholesterol drug by 60 percent, matching an unprecedented move that Amgen made last year.

More From BioPortfolio on "STAT Plus: Pharmalittle: Regeneron and Sanofi drop price on cholesterol drug; abortion pill restrictions are obstacles to docs"